Titan Pharma (TTNP) Tops Q2 EPS by 2c
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Titan Pharma (NASDAQ: TTNP) reported Q2 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15 million versus the consensus estimate of $15 million.
For earnings history and earnings-related data on Titan Pharma (TTNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Gold (ABX) Tops Q3 EPS by 4c
- DDR Corp. (DDR) Tops Q3 FFO by 2c
- Pacific Continental (PCBK) Misses Q3 EPS by 5c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!